Allmed Medical Products Co.,Ltd (SHE:002950)

SHE:002950 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	752.24	585.16	397.04	522.2	678.46	1,302
Short-Term Investments	-	-	2.14	-	-	200
Trading Asset Securities	2.02	83.15	96.82	264.63	8.14	35.63
Cash & Short-Term Investments	754.26	668.32	496	786.84	686.6	1,538
Cash Growth	34.54%	34.74%	-36.96%	14.60%	-55.35%	531.34%
Accounts Receivable	482.78	482.75	391.25	521.56	532.46	295.55
Other Receivables	100.42	72.76	68.01	47.38	56.58	51.75
Receivables	583.19	555.51	459.26	568.94	589.04	347.3
Inventory	533.88	615.27	707.21	877.33	846.63	707.28
Other Current Assets	111.69	88.72	117.08	165.85	120.83	243.85
Total Current Assets	1,983	1,928	1,780	2,399	2,243	2,836
Property, Plant & Equipment	1,763	1,829	1,988	2,019	1,603	1,259
Long-Term Investments	890.38	898.22	905.33	824.79	758.68	403.24
Goodwill	95.3	95.3	98.09	98.09	25.99	-
Other Intangible Assets	175.67	182.78	202.66	213.58	234.75	219.53
Long-Term Accounts Receivable	-	-	-	-	17.05	18.76
Long-Term Deferred Tax Assets	47.4	49.14	56.19	48.88	64	44.14
Long-Term Deferred Charges	5.87	6.76	7.08	4.74	1.14	1.26
Other Long-Term Assets	68.5	69.54	46.95	139.79	57.01	68.85
Total Assets	5,029	5,059	5,084	5,748	5,005	4,856
Accounts Payable	309.88	360.87	326.1	897.32	253.86	143.87
Accrued Expenses	90.74	90.01	76.39	84.96	79.82	73.7
Short-Term Debt	475.23	494.31	749.57	792.09	1,060	1,086
Current Portion of Long-Term Debt	-	69.11	54.2	27.15	99.09	-
Current Portion of Leases	5.4	7.68	6.36	2.1	2.27	-
Current Income Taxes Payable	18.98	24.54	6.29	4.93	35.28	85.78
Current Unearned Revenue	11.9	13.02	64.84	129.32	7.8	52.48
Other Current Liabilities	42.63	48.2	41.7	129.06	100.91	23.44
Total Current Liabilities	954.75	1,108	1,325	2,067	1,639	1,465
Long-Term Debt	41.86	89.17	146.32	111.41	127.61	100
Long-Term Leases	0.97	0.43	4.61	5.37	0.6	-
Long-Term Unearned Revenue	188.99	197.51	191.94	189.68	292.17	220.45
Long-Term Deferred Tax Liabilities	245.66	216.04	199.71	243.16	193.82	147.28
Other Long-Term Liabilities	-	-	5.32	-	-	-
Total Liabilities	1,432	1,611	1,873	2,617	2,253	1,933
Common Stock	633.27	633.27	633.27	633.27	633.27	633.27
Additional Paid-In Capital	580.21	580.21	565.77	565.77	564.49	572.56
Retained Earnings	2,475	2,312	1,960	1,888	1,619	1,745
Treasury Stock	-115.9	-97.89	-	-	-	-
Comprehensive Income & Other	9.9	8.96	28.1	14.32	-63.63	-40.15
Total Common Equity	3,582	3,437	3,187	3,101	2,753	2,911
Minority Interest	15.05	11.51	23.73	29.91	-0.91	12.41
Shareholders' Equity	3,597	3,448	3,211	3,131	2,752	2,923
Total Liabilities & Equity	5,029	5,059	5,084	5,748	5,005	4,856
Total Debt	523.46	660.7	961.06	938.13	1,289	1,186
Net Cash (Debt)	230.8	7.62	-465.06	-151.29	-602.53	351.86
Net Cash Per Share	0.37	0.01	-0.73	-0.24	-0.95	0.56
Filing Date Shares Outstanding	618.76	618.76	621.92	633.27	633.27	633.27
Total Common Shares Outstanding	618.76	618.76	633.27	633.27	633.27	633.27
Working Capital	1,028	820.08	454.08	332.03	604.51	1,371
Book Value Per Share	5.79	5.55	5.03	4.90	4.35	4.60
Tangible Book Value	3,311	3,158	2,886	2,789	2,492	2,691
Tangible Book Value Per Share	5.35	5.10	4.56	4.40	3.94	4.25
Buildings	1,201	1,197	1,220	1,044	989.99	814.48
Machinery	1,832	1,879	2,044	1,679	1,534	1,120
Construction In Progress	67.65	27	18.35	400.62	38.24	72.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.